MET and neoplasm: Among the 70 patients with informative results for both MSP-tumor and PYR-tumor, eight (11.4%) identified as UNMET by MSP-tumor were identified as MET by PYR-tumor; conversely, three (4.3%) identified as MET by MSP-tumor were identified as UNMET by PYR-tumor (p < 0.001) (Table 3).